BACKGROUND: The rates of contralateral prophylactic mastectomy (CPM) are increasing worldwide. This study investigated Australian and New Zealand's breast surgeons' perceptions, knowledge and attitudes towards CPM, and explored if demographic characteristics of surgeons were associated with an increased tendency to recommend or perform CPM. METHODS: A cross sectional research design was employed, with breast surgeons completing a self-report questionnaire. The questionnaire collected information including surgeons' perceptions on CPM in their clinical practice, their attitudes and knowledge of CPM and surgeons' demographic information. RESULTS: Eighty-one of 220 (37%) breast surgeons contacted via BreastSurgANZ participated in this study. Forty-four per cent of surgeons perceived that the rates of CPMs they performed had increased over the last year. CPM rates were found to be unrelated to surgeons' age (P = 0.773) or gender (P = 0.941). The main reasons a surgeon recommended a CPM to patients included known BRCA+ mutation, family history of breast cancer and patient factors including fear and anxiety and a desire to avoid further breast cancer treatment. CONCLUSIONS: Breast surgeons perceived that rates of CPM were increasing in their own clinical practice. CPM rates were unrelated to surgeon demographics including age and gender. While surgeons are aware of the objective risk factors that make performing a CPM advisable, they also report taking into account subjective factors, including patient fear and anxiety and a desire for breast symmetry when recommending a CPM.
BACKGROUND: The rates of contralateral prophylactic mastectomy (CPM) are increasing worldwide. This study investigated Australian and New Zealand's breast surgeons' perceptions, knowledge and attitudes towards CPM, and explored if demographic characteristics of surgeons were associated with an increased tendency to recommend or perform CPM. METHODS: A cross sectional research design was employed, with breast surgeons completing a self-report questionnaire. The questionnaire collected information including surgeons' perceptions on CPM in their clinical practice, their attitudes and knowledge of CPM and surgeons' demographic information. RESULTS: Eighty-one of 220 (37%) breast surgeons contacted via BreastSurgANZ participated in this study. Forty-four per cent of surgeons perceived that the rates of CPMs they performed had increased over the last year. CPM rates were found to be unrelated to surgeons' age (P = 0.773) or gender (P = 0.941). The main reasons a surgeon recommended a CPM to patients included known BRCA+ mutation, family history of breast cancer and patient factors including fear and anxiety and a desire to avoid further breast cancer treatment. CONCLUSIONS: Breast surgeons perceived that rates of CPM were increasing in their own clinical practice. CPM rates were unrelated to surgeon demographics including age and gender. While surgeons are aware of the objective risk factors that make performing a CPM advisable, they also report taking into account subjective factors, including patient fear and anxiety and a desire for breast symmetry when recommending a CPM.
Authors: Meghana G Shamsunder; Hina Panchal; Melissa Pilewskie; Clara Lee; Shantanu N Razdan; Evan Matros Journal: J Am Coll Surg Date: 2021-08-23 Impact factor: 6.532
Authors: Michaela S Tracy; Shoshana M Rosenberg; Laura Dominici; Ann H Partridge Journal: Breast Cancer Res Treat Date: 2013-07-28 Impact factor: 4.872
Authors: Steven J Katz; Nancy K Janz; Paul Abrahamse; Lauren P Wallner; Sarah T Hawley; Lawrence C An; Kevin C Ward; Ann S Hamilton; Monica Morrow; Reshma Jagsi Journal: JAMA Surg Date: 2017-07-01 Impact factor: 16.681
Authors: Nisreen Elsayegh; Jessica Profato; Angelica M Gutierrez Barrera; Heather Lin; Henry M Kuerer; Can Ardic; Jennifer K Litton; Debasish Tripathy; Banu K Arun Journal: J Cancer Date: 2015-05-23 Impact factor: 4.207
Authors: Katharine Yao; Richard Bleicher; Meena Moran; Cecilia Chang; Jill Dietz; Vered Stearns; James Connolly; Terry Sarantou; Scott Kurtzman Journal: Cancer Med Date: 2020-03-11 Impact factor: 4.452